These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19430335)

  • 1. Angiogenesis in the kidney: a new therapeutic target?
    Lerman LO; Chade AR
    Curr Opin Nephrol Hypertens; 2009 Mar; 18(2):160-5. PubMed ID: 19430335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renovascular disease, microcirculation, and the progression of renal injury: role of angiogenesis.
    Chade AR
    Am J Physiol Regul Integr Comp Physiol; 2011 Apr; 300(4):R783-90. PubMed ID: 21307362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?
    Chade AR; Stewart N
    J Am Soc Hypertens; 2013; 7(2):180-90. PubMed ID: 23428409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF therapy for the kidney: emerging strategies.
    Guise E; Chade AR
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F747-F751. PubMed ID: 29442546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of renal microcirculation in experimental renovascular disease.
    Iliescu R; Fernandez SR; Kelsen S; Maric C; Chade AR
    Nephrol Dial Transplant; 2010 Apr; 25(4):1079-87. PubMed ID: 19934087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal vascular structure and rarefaction.
    Chade AR
    Compr Physiol; 2013 Apr; 3(2):817-31. PubMed ID: 23720331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoring the renal microvasculature to treat chronic kidney disease.
    Long DA; Norman JT; Fine LG
    Nat Rev Nephrol; 2012 Feb; 8(4):244-50. PubMed ID: 22310952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease.
    Chade AR; Zhu X; Lavi R; Krier JD; Pislaru S; Simari RD; Napoli C; Lerman A; Lerman LO
    Circulation; 2009 Feb; 119(4):547-57. PubMed ID: 19153272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal microvascular assembly and repair: power and promise of molecular definition.
    Takahashi T; Huynh-Do U; Daniel TO
    Kidney Int; 1998 Apr; 53(4):826-35. PubMed ID: 9551388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF: Potential therapy for renal regeneration.
    Chade AR
    F1000 Med Rep; 2012; 4():1. PubMed ID: 22238513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal Therapeutic Angiogenesis Using a Bioengineered Polymer-Stabilized Vascular Endothelial Growth Factor Construct.
    Chade AR; Tullos NA; Harvey TW; Mahdi F; Bidwell GL
    J Am Soc Nephrol; 2016 Jun; 27(6):1741-52. PubMed ID: 26541349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulating the microvasculature and its microenvironment.
    Krishnan L; Chang CC; Nunes SS; Williams SK; Weiss JA; Hoying JB
    Crit Rev Biomed Eng; 2013; 41(2):91-123. PubMed ID: 24580565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvascular dysfunction and kidney disease: Challenges and opportunities?
    Krishnan S; Suarez-Martinez AD; Bagher P; Gonzalez A; Liu R; Murfee WL; Mohandas R
    Microcirculation; 2021 Apr; 28(3):e12661. PubMed ID: 33025626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remodeling of Cerebral Microcirculation after Ischemia-Reperfusion.
    Lapi D; Colantuoni A
    J Vasc Res; 2015; 52(1):22-31. PubMed ID: 25896412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerotic process, renovascular disease and outcomes from bench to bedside.
    Lerman LO; Chade AR
    Curr Opin Nephrol Hypertens; 2006 Nov; 15(6):583-7. PubMed ID: 17053471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of microvascular networks: role of stromal interactions directing angiogenic growth.
    Hoying JB; Utzinger U; Weiss JA
    Microcirculation; 2014 May; 21(4):278-89. PubMed ID: 24447042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapeutic strategies for renovascular disease.
    Eirin A; Textor SC; Lerman LO
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):383-389. PubMed ID: 31045658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1.
    Kang DH; Joly AH; Oh SW; Hugo C; Kerjaschki D; Gordon KL; Mazzali M; Jefferson JA; Hughes J; Madsen KM; Schreiner GF; Johnson RJ
    J Am Soc Nephrol; 2001 Jul; 12(7):1434-1447. PubMed ID: 11423572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-a receptor blockade improves renal microvascular architecture and function in experimental hypercholesterolemia.
    Chade AR; Krier JD; Textor SC; Lerman A; Lerman LO
    J Am Soc Nephrol; 2006 Dec; 17(12):3394-403. PubMed ID: 17082239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal microvascular disease determines the responses to revascularization in experimental renovascular disease.
    Chade AR; Kelsen S
    Circ Cardiovasc Interv; 2010 Aug; 3(4):376-83. PubMed ID: 20587789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.